ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887,605 | -2.1% | 13,107 | +3.4% | 0.11% | +2.7% |
| Q2 2023 | $906,791 | +5.5% | 12,670 | +2.3% | 0.11% | 0.0% |
| Q1 2023 | $859,433 | +11.4% | 12,382 | +8.8% | 0.11% | +2.8% |
| Q4 2022 | $771,495 | +42.9% | 11,379 | +15.5% | 0.11% | +28.9% |
| Q3 2022 | $540,000 | -33.7% | 9,850 | -20.0% | 0.08% | -29.7% |
| Q2 2022 | $814,000 | +5.0% | 12,316 | +5.3% | 0.12% | +20.4% |
| Q1 2022 | $775,000 | +39.1% | 11,695 | +22.3% | 0.10% | +46.3% |
| Q4 2021 | $557,000 | -2.6% | 9,562 | +0.3% | 0.07% | -11.8% |
| Q3 2021 | $572,000 | +73.3% | 9,530 | +73.2% | 0.08% | +68.9% |
| Q2 2021 | $330,000 | +29.9% | 5,503 | +7.5% | 0.04% | +21.6% |
| Q1 2021 | $254,000 | +22.7% | 5,117 | +35.2% | 0.04% | 0.0% |
| Q3 2020 | $207,000 | +3.5% | 3,785 | 0.0% | 0.04% | -7.5% |
| Q2 2020 | $200,000 | -5.2% | 3,785 | -19.8% | 0.04% | -32.2% |
| Q1 2020 | $211,000 | -10.6% | 4,721 | 0.0% | 0.06% | +9.3% |
| Q4 2019 | $236,000 | +10.3% | 4,721 | -1.4% | 0.05% | 0.0% |
| Q3 2019 | $214,000 | -4.9% | 4,788 | -12.0% | 0.05% | -1.8% |
| Q2 2019 | $225,000 | -13.8% | 5,443 | -15.4% | 0.06% | -16.7% |
| Q1 2019 | $261,000 | -19.4% | 6,437 | -24.3% | 0.07% | -29.8% |
| Q4 2018 | $324,000 | -12.9% | 8,508 | -9.3% | 0.09% | 0.0% |
| Q3 2018 | $372,000 | +3.3% | 9,380 | -8.4% | 0.09% | -6.0% |
| Q2 2018 | $360,000 | -3.7% | 10,241 | -4.1% | 0.10% | -7.4% |
| Q1 2018 | $374,000 | -19.6% | 10,681 | -20.3% | 0.11% | -22.3% |
| Q4 2017 | $465,000 | +8.6% | 13,400 | +6.0% | 0.14% | -0.7% |
| Q3 2017 | $428,000 | -0.2% | 12,642 | +0.6% | 0.14% | -4.1% |
| Q2 2017 | $429,000 | -16.2% | 12,570 | -23.5% | 0.15% | -19.3% |
| Q1 2017 | $512,000 | -41.6% | 16,425 | -48.8% | 0.18% | -45.5% |
| Q4 2016 | $877,000 | -42.4% | 32,107 | -30.7% | 0.33% | -45.2% |
| Q3 2016 | $1,522,000 | +2.2% | 46,324 | -6.0% | 0.61% | +0.8% |
| Q2 2016 | $1,489,000 | +25.0% | 49,307 | +16.5% | 0.60% | +40.7% |
| Q1 2016 | $1,191,000 | +14.9% | 42,312 | +38.6% | 0.43% | +10.1% |
| Q4 2015 | $1,037,000 | +13.3% | 30,532 | +6.2% | 0.39% | +11.5% |
| Q3 2015 | $915,000 | +249.2% | 28,742 | +599.3% | 0.35% | +282.4% |
| Q2 2015 | $262,000 | +9.6% | 4,110 | +21.2% | 0.09% | +2.2% |
| Q4 2014 | $239,000 | -29.3% | 3,391 | -28.2% | 0.09% | -32.1% |
| Q3 2014 | $338,000 | -17.8% | 4,726 | -14.6% | 0.13% | -14.9% |
| Q2 2014 | $411,000 | -37.7% | 5,531 | -45.6% | 0.15% | -43.4% |
| Q1 2014 | $660,000 | -1.3% | 10,169 | -9.8% | 0.27% | -6.5% |
| Q4 2013 | $669,000 | +13.4% | 11,268 | -0.7% | 0.29% | +2.1% |
| Q3 2013 | $590,000 | +7.9% | 11,353 | -1.7% | 0.28% | +17.3% |
| Q2 2013 | $547,000 | – | 11,553 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |